Dreef-Tromp C M, Basten J E, Broekhoven M A, van Dinther T G, Petitou M, van Boeckel C A
N.V. Organon Scientific Development Group, Oss, The Netherlands.
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2081-6. doi: 10.1016/s0960-894x(98)00382-5.
The in vitro antithrombotic activity of synthetic glycoconjugates I and II, comprising a flexible polyethylene glycol type and a rigid polyglucose type spacer, respectively, are compared to heparin.